This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2025 Zacks Investment Research | 101 N Wacker Drive, Floor 15, Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +23.64% per year. These returns cover a period from January 1, 1988 through August 4, 2025. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy, DMCA Policy and Terms of Service apply.
View All Zacks #1 Ranked Stocks
Zacks News
Encompass Health Up 60% in a Year: What Lies Ahead for Investors?
by Zacks Equity Research
EHC remains well-poised for growth on the back of solid discharge growth, an aging U.S. population, frequent expansion initiatives and strong cash reserves.
MDT Stock May Gain Following the Positive Data From Optimize PRO Study
by Zacks Equity Research
Medtronic announces new positive data for its Evolut TAVR from the Optimize PRO clinical research.
Here's Why You Should Retain PDCO Stock in Your Portfolio for Now
by Zacks Equity Research
Investors remain optimistic about Patterson Companies on the back of its broad product line.
GEHC Stock May Gain Following the Launch of Pristina Via System
by Zacks Equity Research
GE HealthCare announces the Pristina Via mammography system, which will help minimize repetitive tasks and streamline workflows for mammography technologists.
Here's Why You Should Retain Ecolab Stock in Your Portfolio Now
by Zacks Equity Research
ECL continues to gain from its strong segmental performance and improved operating margin.
STXS Stock Up Following the NMPA Clearance of Its Genesis RMN System
by Zacks Equity Research
Stereotaxis, in collaboration with MicroPort EP, announces the receipt of NMPA approval for its Genesis RMN System.
Reasons to Retain Intuitive Surgical Stock in Your Portfolio Now
by Zacks Equity Research
ISRG's strength in robotics continues to raise optimism among investors.
Will Ambry Genetics Acquisition Drive Tempus AI's Prospects?
by Zacks Equity Research
TEM acquires Ambry Genetics, expanding its testing portfolio and redefining precision medicine.
GEHC Stock May Gain on Its Enhanced OEC 3D Mobile CBCT C-Arm Portfolio
by Zacks Equity Research
GE HealthCare announces the latest application additions to its OEC 3D mobile CBCT C-arm portfolio to improve clinician workflow and visualization during endoscopic bronchoscopy procedures.
CAH Stock Gains on the Launch of Kendall SmartFlow Compression System
by Zacks Equity Research
Cardinal Health launches the next generation of the Kendall Compression Series, Kendall SCD SmartFlow Compression System, to aid pain relating to venous stasis.
DexCom and OURA Ink Partnership for Metabolic Health Innovation
by Zacks Equity Research
DXCM and smart ring maker, OURA, join forces to help individuals make informed decisions regarding diet, exercise and overall well-being.
Cencora Rallies 19.7% Year to Date: What's Driving the Stock?
by Zacks Equity Research
COR is gaining traction from the robust U.S. Healthcare Solutions segment, which raises optimism about the stock.
McKesson Stock Gains 34.1% YTD: What's Driving the Rally?
by Zacks Equity Research
MCK continues to gain because of robust segmental performance and raised fiscal 2025 guidance.
Veeva Stock May Gain on the Launch of GenAI Features in Vault CRM
by Zacks Equity Research
VEEV announces GenAI capabilities, CRM Bot and Voice Control, for its Vault CRM.
Glaukos Stock Soars 77.9% Year to Date: What's Behind the Rally?
by Zacks Equity Research
GKOS stock gains from strong product demand, international expansion and pipeline progress, which position it for long-term growth despite supply risks.
GEHC Stock Likely to Gain on Portrait Mobile Solution's Prospects
by Zacks Equity Research
GE HealthCare's Portrait Mobile solution will provide continuous monitoring in post-surgery settings. It will also deliver informative alarms, advancing patient care while alleviating the burdens faced by clinicians.
Is SPDR S&P Health Care Equipment ETF (XHE) a Strong ETF Right Now?
by Zacks Equity Research
Smart Beta ETF report for XHE
HealthEquity Gains 54.6% YTD: What's Driving the Stock?
by Zacks Equity Research
HQY's sustained strength in HSAs raises optimism about the stock.
Stryker Stock May Gain From Oculan Lighting Platform's Launch
by Zacks Equity Research
SYK launches the Oculan Lighting Platform to improve lighting conditions in the operating rooms and allow surgeons to perform with more accuracy.
NVRO Stock Declines Despite Positive Study Data of Nevro1 System
by Zacks Equity Research
Nevro unveils publication of positive data study regarding its Nevro1 SI Joint Fusion System.
Reasons to Hold West Pharmaceutical Stock in Your Portfolio Now
by Zacks Equity Research
WST continues to gain momentum due to its strength in the Pharma market unit. However, decline across its Generics and Biologics business units is concerning.
INBS Stock Declines Despite Positive Results of Pharmacokinetic Study
by Zacks Equity Research
Intelligent Bio Solutions unveils strong initial results for its PK study, which is important for FDA submission of its Intelligent Fingerprinting Drug Screening System.
LivaNova's OSPREY Sleep Apnea Trail on aura6000 Meets Primary Endpoint
by Zacks Equity Research
LIVN's aura6000 significantly increases responder rates. The device also reduces AHI and ODI levels. A premarket approval application will be filed soon.
GE HealthCare and DeepHealth Collaborate to Advance AI in Imaging
by Zacks Equity Research
GEHC and DeepHealth collaborate to develop AI-based imaging tools that can streamline workflow and help manage large imaging volumes without compromising diagnostic accuracy.
SOLV Stock Falls Despite Launch of Clarity Precision Grip Attachments
by Zacks Equity Research
Solventum's Clarity precision grip attachments enhance treatment outcomes for orthodontic patients, reducing the risk of misplaced and malformed attachments.